The Investor Globe

  Home   |  Business   |  Personal Finance   |  Gold   |  World   |  USA   |  China   |  India   |  Middle East   |  Bitcoin   |  Techno   |  Blogs   |  M & A   |  IPO

Top Stories on Cymbalta

Lilly Profit Beats Analyst Estimates as Cymbalta Sales Rise - Bloomberg

Eli Lilly & Co. (LLY), maker of the schizophrenia medicine Zyprexa, reported second-quarter profit that fell less than analysts estimated after higher sales for the antidepressant Cymbalta helped trim losses from generic competition to its ...

Drug Giants Show Mixed Earnings - Marketwatch

Surging growth of its Cymbalta depression treatment helped Eli Lilly & Co. (NYSE: LLY) beat Wall St.'s earnings expectations. But generic rivals to Plavix, other drugs hurt Bristol-Myers Squibb Co. (NYSE: BMY) second-quarter results. Eli Lilly ...

For the Treatment of Fibromyalgia, Eli Lilly/Boehringer Ingelheim?s Cymbalta Was the Patient- and Market-Share Leading Agent - Bloomberg

For the Treatment of Fibromyalgia, Eli Lilly/Boehringer Ingelheim?s Cymbalta Was the Patient- and Market-Share Leading Agent in the United States in 2011, after Surpassing Pfizer?s Lyrica in 2010 The United States Accounted for Nearly 80 ...

Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing - Marketwatch

ranging from management positions in the major pharmaceutical industry at Eli Lilly where he participated in the launch of Prozac and the early development of Zyprexa, Strattera and Cymbalta, and Johnson & Johnson where he held the ...

Bristol-Myers, Lilly Post 2Q Sales Declines as Blockbusters Lose Exclusivity - FOXBusiness

Losses for the Indianapolis-based drug maker were partially stemmed by a 22% revenue increase in depression drug Cymbalta and double-digit improvements in Lilly?s pharmaceutical businesses in China and Japan. "Despite the continued decline in ...

Lilly Issues Sunny Outlook On Sales Of Depression Drug - NASDAQ

However, earnings topped Wall Street estimates, helped by higher revenues for depression drug Cymbalta, and the drugmaker lifted its full year earnings view. John Lechleiter, CEO, said, "Despite the continued decline in Zyprexa sales following ...

Lilly's Q2 profit drop softer than expected - Indianapolis Star

Cheaper copies of Zyprexa came on the market last year, and next year exclusivity ends for the company?s best-seller, the antidepressant Cymbalta. Investors are shifting attention to Lilly?s drugs in development, including an Alzheimer?s ...

Lilly beats 2nd-quarter profit view, raises 2012 forecast - Reuters India

July 25 (Reuters) - Eli Lilly and Co's quarterly earnings beat Wall Street expectations, helped by surging growth of its Cymbalta depression treatment, and the company raised its 2012 profit outlook, thanks to the favorable impact of a stronger dollar.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/script>
 

/script>
 
Blogspot logo    Latest Posts from Marc Faber blog
 
Blogspot logo    Latest Posts from Henrique Simoes blog
 
  Latest Posts from Mad Money 
Cramer Remix: The key chart patterns all investors should keep in mind
Cramer unveils the scariest pattern in the chart book
Cramer shares the unusual signs that mean a stock is ready to explode
Cramer's guide to finding bulletproof stocks using charts
Cramer: How to use charts to detect a phony rally on Wall Street
 
   Latest Posts from Fast Money
'Ugly correction' coming: Dennis Gartman
Your first trade for Tuesday
Retail terrified by EEM: Pro
Stock Pops & Drops: AOL, FEYE, JOSB & RYAAY
Second leg of bond rally: Pro
 
 Latest Posts from Bill Cara blog
Tables & Charts for Wednesday, Apr 17th, 2013
Bill Cara's Blog for Apr 17, 2013
Tables & Charts for Tuesday, Apr 16th, 2013
Bill Cara's Blog for Apr 16, 2013
Tables & Charts for Monday, Apr 15th, 2013
 
logo    Latest Posts from Kirk Report

Warning: MagpieRSS: Failed to parse RSS file. (XML_ERR_NAME_REQUIRED at line 1, column 2) in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\rss_fetch.inc on line 414

Warning: array_slice() expects parameter 1 to be array, null given in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\products-on-the-news.php on line 436

Warning: Invalid argument supplied for foreach() in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\products-on-the-news.php on line 437
 
Blogspot logo    Latest Posts from Random Roger
A Financial Advisor Has Got To Know His Limitations
A Lot of Market Stuff & the Maui Invitational!
Shiller Is Wrong
Very Odd And Unfamiliar Crimson Hue On My Screens
Don?t Get Done In By Unintended Overweight Exposure
 
  Home

  Business News
  Personal Finance
  World News
  U.S. News
  China News
  India News
  Middle East News
  Technology
  Blogs

  Mergers and Acquisitions
  IPO (initial Public Offering)
  Bernard Madoff
  Geneal Motors Bankruptcy
  Food prices crisis

  Sitemap
  Gold
  Silver
  Platinum
  Palladium
  Rhodium

         

               
                 Copyright Leaderglobe.